In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients

Abstract

These results indicate that simvastatin in commonly used doses has an in vitro and in vivo anti-inflammatory effect in CKD patients, and may play an important role in counteracting the mechanisms involved on the pathogenesis of cardiovascular disease.